Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,290 | 200 | 98.1% |
| Education | $64.01 | 4 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $422.39 | 29 | $0 (2019) |
| PFIZER INC. | $410.48 | 23 | $0 (2021) |
| Lilly USA, LLC | $327.90 | 19 | $0 (2019) |
| ABBVIE INC. | $301.75 | 17 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $257.50 | 14 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $215.13 | 13 | $0 (2019) |
| Astellas Pharma US Inc | $201.31 | 10 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $161.85 | 12 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $135.81 | 10 | $0 (2019) |
| Novo Nordisk Inc | $111.71 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.69 | 1 | Novo Nordisk Inc ($13.69) |
| 2023 | $40.81 | 2 | Astellas Pharma US Inc ($22.04) |
| 2022 | $108.40 | 5 | ABBVIE INC. ($85.68) |
| 2021 | $167.06 | 8 | AbbVie Inc. ($92.41) |
| 2019 | $640.83 | 38 | PFIZER INC. ($111.40) |
| 2018 | $1,101 | 67 | GlaxoSmithKline, LLC. ($242.93) |
| 2017 | $1,282 | 83 | Lilly USA, LLC ($167.52) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Diabetes | ||||||
| 06/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Biological | ||||||
| 04/26/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEPHROLOGY | ||||||
| 09/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROSCIENCE | ||||||
| 01/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: PRIMARY CARE | ||||||
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: PRIMARY CARE | ||||||
| 06/17/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: GASTROINTESTINAL | ||||||
| 05/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/08/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiology | ||||||
| 11/08/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: Cardiovascular | ||||||
| 11/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.00 | General |
| Category: Cardiovascular | ||||||
| 09/03/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes Care | ||||||
| 07/22/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/22/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Diabetes | ||||||
| 07/19/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 45 | 55 | $21,265 | $3,368 |
| 2022 | 3 | 127 | 182 | $64,036 | $12,748 |
| 2021 | 2 | 112 | 145 | $37,705 | $11,310 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 32 | $14,112 | $2,479 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 23 | $7,153 | $888.84 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 85 | $37,485 | $7,240 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 81 | $25,191 | $5,014 | 19.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $1,360 | $493.43 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 86 | $18,836 | $5,797 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 59 | $18,869 | $5,513 | 29.2% |
About Dr. Aaron Thomas, D.O
Dr. Aaron Thomas, D.O is a Family Medicine healthcare provider based in Newburyport, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902997885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Thomas, D.O has received a total of $3,354 in payments from pharmaceutical and medical device companies, with $13.69 received in 2024. These payments were reported across 204 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,290).
As a Medicare-enrolled provider, Thomas has provided services to 284 Medicare beneficiaries, totaling 382 services with total Medicare billing of $27,426. Data is available for 3 years (2021–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Newburyport, MA
- Active Since 09/27/2006
- Last Updated 02/27/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902997885
Products in Payments
- ELIQUIS (Drug) $313.35
- CHANTIX (Drug) $285.60
- TRULICITY (Drug) $265.40
- ANORO (Drug) $170.65
- UBRELVY (Drug) $140.00
- JANUVIA (Drug) $135.81
- JARDIANCE (Drug) $126.63
- Myrbetriq (Drug) $110.15
- ENTRESTO (Drug) $104.83
- TRELEGY ELLIPTA (Drug) $94.99
- SYMBICORT (Drug) $81.31
- TOUJEO (Drug) $79.00
- INVOKANA (Drug) $78.06
- XARELTO (Drug) $77.77
- NUCALA (Biological) $68.55
- INTRAROSA (Drug) $57.99
- Ozempic (Drug) $57.05
- STIOLTO (Drug) $56.24
- VIAGRA (Drug) $53.39
- XIFAXAN (Drug) $52.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Newburyport
Mark Su, M.d, M.D
Family Medicine — Payments: $2,116
Kirubakaran Siva, Do, DO
Family Medicine — Payments: $740.45
Kevin Lanphear, D.o, D.O
Family Medicine — Payments: $31.01
Judiann Mcghee, M.d, M.D
Family Medicine
Dr. Paul Turnquist, M.d, M.D
Family Medicine
Dr. Richard Traister, M.d, M.D
Family Medicine